InvestSMART

Telix Pharmaceuticals Limited (ASX: TLX) - Announcements

Current share price for TLX : $16.170 0.84 (5.48%)+

ASX company news and announcements for Telix Pharmaceuticals Limited (TLX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Telix Pharmaceuticals Limited (TLX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Telix Pharmaceuticals Limited (TLX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Telix Pharmaceuticals Limited (TLX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$5,488 Becoming a substantial holder 25 Jun 2026 8:16AM $15.730 $16.170 risen by 2.80%
$5,488 Ceasing to be a substantial holder 23 Jun 2026 5:32PM $14.560 $16.170 risen by 11.06%
$5,488 Appendix 3Y Change in Director Interest D Gill 17 Jun 2026 8:24AM $13.850 $16.170 risen by 16.75%
$5,488 Change in substantial holding 9 Jun 2026 8:13AM $13.310 $16.170 risen by 21.49%
$5,488 Notification regarding unquoted securities - TLX 1 Jun 2026 3:26PM $13.035 $16.170 risen by 24.05%
$5,488 Appendix 3Y Change in Director Interest - C Behrenbruch 1 Jun 2026 3:20PM $13.035 $16.170 risen by 24.05%
$5,488 Appendix 3Y Change in Director Interest - M McDonald 1 Jun 2026 3:16PM $13.010 $16.170 risen by 24.29%
$5,488 Appendix 3Y Change in Director Interest - W Jellison 1 Jun 2026 3:15PM $13.010 $16.170 risen by 24.29%
$5,488 Appendix 3Y Change in Director Interest - Maria Rivas 1 Jun 2026 3:12PM $13.010 $16.170 risen by 24.29%
$5,488 Appendix 3Y Change in Director Interest - David Gill 1 Jun 2026 3:11PM $13.010 $16.170 risen by 24.29%
$5,488 Becoming a substantial holder 26 May 2026 4:50PM $13.230 $16.170 risen by 22.22%
$5,488 Results of Annual General Meeting 21 May 2026 1:00PM $14.280 $16.170 risen by 13.24%
$5,488 Telix Annual General Meeting Presentation 21 May 2026 9:39AM $14.000 $16.170 risen by 15.50%
$5,488 Telix Annual General Meeting Chairman and CEO Addresses 21 May 2026 9:38AM $14.000 $16.170 risen by 15.50%
$5,488 App 3X Initial Director Interests - W Jellison 14 May 2026 9:27AM $14.520 $16.170 risen by 11.36%
$5,488 App 3X Initial Director Interests - M Rivas 14 May 2026 9:21AM $14.520 $16.170 risen by 11.36%
$5,488 App 3X Initial Director Interests - D Gill 14 May 2026 9:20AM $14.520 $16.170 risen by 11.36%
$5,488 Change in substantial holding 11 May 2026 6:01PM $14.950 $16.170 risen by 8.16%
$5,488 Cleansing Notice 8 May 2026 10:14AM $14.650 $16.170 risen by 10.38%
$5,488 Application for quotation of securities - TLX 8 May 2026 9:10AM $15.090 $16.170 risen by 7.16%
$5,488 Notification regarding unquoted securities - TLX 8 May 2026 9:04AM $15.090 $16.170 risen by 7.16%
$5,488 Ceasing to be a substantial holder from CGF 6 May 2026 4:28PM $15.210 $16.170 risen by 6.31%
$5,488 Appendix 3Y Change in Director Interests - C Behrenbruch 30 Apr 2026 8:14AM $15.000 $16.170 risen by 7.80%
$5,488 Pending Release of Shares from Voluntary Escrow 29 Apr 2026 5:56PM $15.000 $16.170 risen by 7.80%
$5,488 Change in substantial holding 29 Apr 2026 8:18AM $14.740 $16.170 risen by 9.70%

1 - 25 of 936 results

Page 1 of 38

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.